Communications Medicine (Oct 2023)

Impact of individual and environmental factors on dietary or lifestyle interventions to prevent type 2 diabetes development: a systematic review

  • Dhanasekaran Bodhini,
  • Robert W. Morton,
  • Vanessa Santhakumar,
  • Mariam Nakabuye,
  • Hugo Pomares-Millan,
  • Christoffer Clemmensen,
  • Stephanie L. Fitzpatrick,
  • Marta Guasch-Ferre,
  • James S. Pankow,
  • Mathias Ried-Larsen,
  • Paul W. Franks,
  • ADA/EASD PMDI,
  • Deirdre K. Tobias,
  • Jordi Merino,
  • Viswanathan Mohan,
  • Ruth J. F. Loos

DOI
https://doi.org/10.1038/s43856-023-00363-0
Journal volume & issue
Vol. 3, no. 1
pp. 1 – 17

Abstract

Read online

Abstract Background The variability in the effectiveness of type 2 diabetes (T2D) preventive interventions highlights the potential to identify the factors that determine treatment responses and those that would benefit the most from a given intervention. We conducted a systematic review to synthesize the evidence to support whether sociodemographic, clinical, behavioral, and molecular factors modify the efficacy of dietary or lifestyle interventions to prevent T2D. Methods We searched MEDLINE, Embase, and Cochrane databases for studies reporting on the effect of a lifestyle, dietary pattern, or dietary supplement interventions on the incidence of T2D and reporting the results stratified by any effect modifier. We extracted relevant statistical findings and qualitatively synthesized the evidence for each modifier based on the direction of findings reported in available studies. We used the Diabetes Canada Clinical Practice Scale to assess the certainty of the evidence for a given effect modifier. Results The 81 publications that met our criteria for inclusion are from 33 unique trials. The evidence is low to very low to attribute variability in intervention effectiveness to individual characteristics such as age, sex, BMI, race/ethnicity, socioeconomic status, baseline behavioral factors, or genetic predisposition. Conclusions We report evidence, albeit low certainty, that those with poorer health status, particularly those with prediabetes at baseline, tend to benefit more from T2D prevention strategies compared to healthier counterparts. Our synthesis highlights the need for purposefully designed clinical trials to inform whether individual factors influence the success of T2D prevention strategies.